| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin 53706
After an introduction to the "Session on Skin" emphasizing that some early biochemical changes occurring in the two-stage model system for skin would be presented in the three following presentations, several background experiments were discussed.
It was shown that a complete carcinogen for the skin (7,12-dimethylbenz[a]anthracene) provides both initiating and promoting components, but as the dose level of the carcinogen is lowered its promoting activity is lost while its initiating activity is retained. At the dose level that is completely carcinogenic, 7,12-dimethylbenz[a]anthracene exhibits the properties of a promoter; it stimulates RNA, protein, and DNA synthesis followed by cell division. At initiating doses, both the biochemical and morphological (increased mitosis) responses to treatment that are characteristic of promoters are lost; the remaining biochemical effects involve DNA and are attributed to initiating action.
Some of the data supporting the concept that the mechanism of action of tumor promotion involves gene activation were reviewed.
1 Presented at the Conference "Early Lesions and the Development of Epithelial Cancer," October 21 to 23, 1975. Bethesda, Md. This work was supported in part by grants from the American Cancer Society (BC-14) and from NIH (CA-07175 and CA-05002).
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |